Tirzepatide and major adverse limb events: Insights from a multicenter real-world analysis in PAD and diabetes patients

Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes

Rena R. Wing, Wei Lang, Thomas A. Wadden et al. · Diabetes Care · 2011 · 1.8K citations · Full text

Medicine, Chronic Disease Control, Chronic Disease Prevention +17

The Propensity Score

Jason S. Haukoos, Roger Lewis · JAMA · 2015 · 833 citations · Full text

Medicine, Neurology, Otolaryngology +6

Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity

Patricia J. Rodriguez, Brianna M. Goodwin Cartwright, Samuel Gratzl et al. · JAMA Internal Medicine · 2024 · 268 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +17

The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial

Ketan Dhatariya, Stephen C. Bain, John B. Buse et al. · Diabetes Care · 2018 · 131 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials

Frederick Berro Rivera, Linnaeus Louisse A. Cruz, John Vincent Magalong et al. · American Journal of Preventive Cardiology · 2024 · 123 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +16